Business Context and Reporting Period
Company: Community Health Systems, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 26, 2018 (Earliest event reported: March 23, 2018)
Event: Entry into a Material Definitive Agreement regarding the amendment and restatement of the Company's Credit Agreement.
Key Financial Metrics and Debt Structure
This filing details a restructuring of the Company's credit facilities rather than reporting operational financial results (revenue, profit, or cash flow). Key debt metrics disclosed include:
- Term G Loans Principal: $1,037,348,605.50
- Term H Loans Principal: $1,902,634,486.07
- Term G Interest Rate: LIBOR + 3.00% or Base Rate + 2.00%
- Term H Interest Rate: LIBOR + 3.25% or Base Rate + 2.25%
- Proposed ABL Facility: Up to $1,000,000,000
- Revolving Credit Commitments: To be reduced to $425,000,000 upon effectiveness of the ABL facility
Note: The filing text does not provide clear values for revenue, net income, operating cash flow, or liquidity ratios.
Material Changes Versus Prior Period
The Fourth Amendment and Restatement Agreement introduces the following material changes to the existing Credit Agreement:
- Financing Options: The Borrower is now permitted to incur debt under either a new Asset-Based Loan (ABL) facility or maintain its existing Asset-Backed Securitization program.
- Covenant Modification: The secured net leverage incurrence test with respect to junior secured debt has been removed.
- Commitment Adjustment: Revolving credit commitments are scheduled to decrease to $425 million contingent on the activation of the ABL facility.
Outlook, Risks, and Management Commentary
Management Commentary: The Company, through its subsidiary CHS/Community Health Systems, Inc., executed the agreement with requisite lender approval to restructure its debt obligations. Credit Suisse AG serves as the administrative and collateral agent.
Risks and Contingencies: The summary of the agreement is qualified by the full text of the agreement (Exhibit 10.1). The reduction in revolving credit commitments is contingent upon the effectiveness of the contemplated ABL facility.
Investor Verification Checklist
- Verify the full terms of the Fourth Amendment and Restatement Agreement in Exhibit 10.1.
- Confirm the status of the Asset-Based Loan (ABL) facility and whether the $425 million reduction in revolving commitments has been triggered.
- Review the impact of the removed secured net leverage incurrence test on future borrowing capacity for junior secured debt.
- Assess the interest rate exposure given the LIBOR and Base Rate spreads for Term G and Term H loans.